Cameroon's MDR-TB treatment programme jeopardised by cross-border migration

Eur Respir J. 2016 Feb;47(2):684-6. doi: 10.1183/13993003.01324-2015.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Communicable Disease Control / organization & administration*
  • Developed Countries*
  • Female
  • Global Health*
  • Humans
  • Male
  • Tuberculosis / drug therapy*
  • Tuberculosis / prevention & control*

Substances

  • Antitubercular Agents